This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages without signing in

Visual field defects (and vigabatrin)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • diplopia is a well-known side effect, in common with other anti-epileptic drugs (1)

  • visual field defects (e.g. tunnel vision) have been reported whilst on vigabatrin therapy. The onset of the visual field defect varies from one month to several years after starting vigabatrin. Visual field loss associated with use of vigabatrin appears to be irreversible, even after cessation of therapy

Reference:

  • Current Problems in Pharmacovigilance (1999), 25, 13.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.